Fresenius | FRE - Operating Profit


Fresenius reported EUR719M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Akzo Nobel EUR 251M 3M Jun/2026
Alcon AG USD 297M 16M Mar/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
BASF EUR 1.43B 31M Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Beiersdorf EUR 504M 312M Dec/2025
DaVita Healthcare Partners USD 473.55M 110.66M Mar/2026
Demant DKK 2.09B 224M Dec/2025
E.ON EUR 4.11B 3.05B Mar/2026
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 268M 395M Mar/2026
Getinge SEK 1.35B 268M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GN Store Nord DKK -68M 638M Mar/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
RWE EUR -139M 716M Mar/2026
Sanofi EUR 2.38B 449M Jun/2026
Smith & Nephew USD 505M 65M Jun/2026